Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Fujimura

Showing results (171-180 of 283) with videos related to

Pageof 29
Sort By:
Frontiers in Immunology|November 12, 2020
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell CarcinomaYota Sato, Taku Fujimura, Takanori Hidaka, et al.
Experimental Dermatology|August 24, 2017
Cytotoxic antimelanoma drugs suppress the activation of M2 macrophagesTaku Fujimura, Aya Kakizaki, Yumi Kambayashi, et al.
The Journal of Dermatology|April 26, 2017
Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signalingSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|March 9, 2018
Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide MonotherapyTaku Fujimura, Kayo Tanita, Yota Sato, et al.
The Journal of Dermatology|April 16, 2020
Severe pyrexia from nivolumab-resistant advanced melanoma after successful combined therapy with encorafenib plus binimetinibRyo Amagai, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|April 21, 2020
Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination TherapyTaku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, et al.
Dermatologic Therapy|December 28, 2021
Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: A case reportMayuko Amagai, Maki Ozawa, Ryo Amagai, et al.
Case Reports in Dermatology|December 29, 2012
Cutaneous squamous cell carcinoma developing from recessive dystrophic epidermolysis bullosa: a case report and an immunohistochemical studyAkira Tsukada, Taku Fujimura, Sadanori Furudate, et al.
Frontiers in Medicine|July 13, 2019
Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor ResectionTaku Fujimura, Yumi Kambayashi, Yota Sato, et al.
Neuroreport|November 11, 2014
Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility geneShinya Sonobe, Miki Fujimura, Kuniyasu Niizuma, et al.
Pageof 29

Showing results (171-180 of 283) with videos related to

Sort By:
Pageof 29
Frontiers in Immunology|November 12, 2020
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell CarcinomaYota Sato, Taku Fujimura, Takanori Hidaka, et al.
Experimental Dermatology|August 24, 2017
Cytotoxic antimelanoma drugs suppress the activation of M2 macrophagesTaku Fujimura, Aya Kakizaki, Yumi Kambayashi, et al.
The Journal of Dermatology|April 26, 2017
Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signalingSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|March 9, 2018
Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide MonotherapyTaku Fujimura, Kayo Tanita, Yota Sato, et al.
The Journal of Dermatology|April 16, 2020
Severe pyrexia from nivolumab-resistant advanced melanoma after successful combined therapy with encorafenib plus binimetinibRyo Amagai, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|April 21, 2020
Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination TherapyTaku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, et al.
Dermatologic Therapy|December 28, 2021
Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: A case reportMayuko Amagai, Maki Ozawa, Ryo Amagai, et al.
Case Reports in Dermatology|December 29, 2012
Cutaneous squamous cell carcinoma developing from recessive dystrophic epidermolysis bullosa: a case report and an immunohistochemical studyAkira Tsukada, Taku Fujimura, Sadanori Furudate, et al.
Frontiers in Medicine|July 13, 2019
Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor ResectionTaku Fujimura, Yumi Kambayashi, Yota Sato, et al.
Neuroreport|November 11, 2014
Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility geneShinya Sonobe, Miki Fujimura, Kuniyasu Niizuma, et al.
Pageof 29